Dishing The Science with Dr. Sue
Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine.
Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixed in too! With over 20 years (and counting) of experience as a physician, I always report, share, and interpret the information with the person living with obesity or diabetes as the focus. With nearly 3 million hits on my blog to date, I am sure you will find something important to you/your patients. I'm excited to share this journey with you!
Episodes
91 episodes
What happens if you stop weight management medication, and what do our new Obesity Canada Guidelines advise?
Some people on weight management medication may want to stop treatment because of cost, or perhaps because they want to again try 'doing it on their own'. What do our new Obesity Canada 2025 Clinical Practice Guidelines recommend on this topic?...
•
5:29
OBESITY CANADA 2025 PHARMACOTHERAPY GUIDELINES: WHAT COULDN’T WE ANSWER?
In our NEW 2025 Obesity Canada Pharmacotherapy Clinical Practice Guidelines, we identified many existing gaps where data is lacking. Where did our Guidelines leave us wanting for more? Where is more research needed? Find out here!Learn m...
•
4:20
OBESITY CANADA PHARMACOTHERAPY clinical practice GUIDELINES 2025 – PUBLISHED!
As the lead author, I am thrilled to ANNOUNCE publication of our long-awaited 2025 Obesity Canada Clinical Practice Guidelines! Includes 13 recommendations, a brand new Decision Tool&Table to guide in the choice of medication, Key Mes...
•
4:51
Can weight loss medications improve erectile dysfunction (ED)?
Erectile dysfunction (ED) is common in men with elevated weight. Can weight loss medications improve ED?Learn more: https://drsue.ca/2025/08/...
•
5:20
How does Mounjaro stack up for cardiovascular protection? The SURPASS CVOT results
In choosing the best GLP1-based medication for our patients with type 2 diabetes at high risk of cardiovascular disease, guidelines recommend choosing one that has proven reduction in risk of CV events in cardiovascular outcome trials (CVOTs). ...
•
5:56
Can creatine supplements preserve muscle during weight loss?
Can creatine supplements preserve muscle during weight loss? Learn more: https://drsue.ca/2025/07/can-creatine-supplements-preserve-musc...
•
3:45
Sleep is a nutrient!
We often talk about sleep as a luxury in our busy lives. But what if we redefined sleep entirely? What if we thought of sleep like an essential vitamin – non-negotiable, restorative, and vital? It’s time we start seeing sleep as a nutrient....
•
4:10
Could GLP1 weight loss/diabetes medications benefit skin conditions like psoriasis or hidradenitis suppurativa?
As we gain 20+ years of experience with GLP1-based treatment, I continue to be fascinated by the diversity of potential benefits that we are finding in clinical trials and in clinical practice. A fascinating article was recently published...
•
4:34
Will once-a-month weight loss medication be a next big step forward?
Could the next generation of weight management medications include treatments given just once a month? Find out more here!Learn more:
•
4:44
Wegovy Plus Amylin: CagriSema weight management results revealed!
I was honored to present results of CagriSema - Wegovy+Amylin (cagrilintide) - as an up-and-coming weight managment medication at the American Diabetes Association meeting yesterday, with simultaneous publication of our results in the New Engla...
•
8:33
Could risk of heart attack and stroke risk rise decades before type 2 diabetes diagnosis?
Diabetes is a risk factor for cardiovascular (CV) disease. But could the risk of heart attack and stroke be elevated, even DECADES before the diagnosis of type 2 diabetes is made? Find out more here!Learn more:
•
3:48
Mazdutide: First phase 3 GLP1/glucagon dual agonist weight management results
Could GLP1 and glucagon work together to provide weight loss benefits and improvement to metabolic and liver health? Find out about the results of the first phase 3 study of a dual GLP1/glucagon receptor agonist (mazdutide) here! Le...
•
4:46
What do people list as Top 3 risks of weight management medication? (and none of them are side effects)
When we as doctors think about risks of any medication, the first thing that comes to mind is the potential for side effects. But when I ask my patients what they perceive as potential risks of treatment, often the answer is something else enti...
•
4:59
Zepbound (Mounjaro) for weight management approved in Canada!
Tirzepatide, which has been approved in Canada as a diabetes medication (Mounjaro) since 2022, received Health Canada approval for weight management this week (called Zepbound). What do you need to know?Learn more:
•
4:49
Zepbound/Mounjaro and Wegovy face off!
Zepbound/Mounjaro and Wegovy face off in a head-to-head trial. How did they compare? Learn more: https://drsue.ca/2025/05/zepbound-mounjaro-and-wegovy-f...
•
5:43
Can weight loss with obesity medication reduce risk for revisional surgery after hip or knee replacement?
For a person living with obesity who has had already had a hip or knee replaced, can weight loss with obesity medication reduce the risk of needing a revisional surgery?Learn more:
•
3:44
Should vitamins be prescribed with weight management medication?
With the significant reduction in food intake that highly efficacious weight management medications can induce, it's important to consider whether a person is getting adequate nutritional and nutrient intake with treatment. Today I ask th...
•
5:39
The hidden disease: Peripheral artery disease (and what we can do about it)
While heart attack and stroke risk are top of mind for clinicians, peripheral artery disease is often overlooked. What are the symptoms, how is it diagnosed, and what can we do about it?Learn more:
•
4:47
First GLP1 in a pill to reduce cardiovascular events in people with type 2 diabetes
We know that several INJECTABLE GLP1 receptor agonists reduce cardiovascular events in people with type 2 diabetes. Now published is the first study ever to show that a GLP1 in a PILL can reduce cardiovascular events as well. Read on to learn m...
•
4:27
Could shame and blame be a reason why some people say no to weight loss medication?
Could (an often secret) feeling of shame and blame be a reason why some people say no to weight loss medication?Learn more:
•
3:44
Could the bacteria in your gut be driving weight gain?
While we know that hormones and genetics play a big role in the physiology of hunger, there are around a trillion other reasons that are getting more credit for their contributions - learn about these microcritters here!Learn more:
•
2:47
When you take weight loss medication, which other medications may need adjusting?
When taking weight management medication, it's important not to overlook the impact this can have on other medications taken for other health concerns. What are some of the medications that we need to think about?Learn more:
•
4:58
Could GLP1-based weight management medications help sperm quality?
Some men with elevated weight struggle with infertility. Given the weight and metabolic benefits of GLP1 receptor agonists, could GLP1 based weight management medications like liraglutide (Saxenda), semaglutide (Wegovy), or tirzepatide (Mounjar...
•
3:59